- Home
- HERE vs ALEC Comparison
HERE vs ALEC Comparison
Compare HERE & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HERE | ALEC |
|---|---|---|
| Founded | 2019 | 2013 |
| Country | China | United States |
| Employees | 714 | N/A |
| Industry | Other Consumer Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 193.1M | 228.7M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | HERE | ALEC |
|---|---|---|
| Price | $1.90 | $1.97 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $4.83 |
| AVG Volume (30 Days) | 150.0K | ★ 869.6K |
| Earning Date | 06-05-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $21,045,000.00 |
| Revenue This Year | N/A | $2.03 |
| Revenue Next Year | $79.29 | $29.87 |
| P/E Ratio | $2.83 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.50 | $1.09 |
| 52 Week High | $5.80 | $3.40 |
Technical Indicators
Market Signals| Indicator | HERE | ALEC |
|---|---|---|
| Relative Strength Index (RSI) | 39.88 | 53.89 |
| Support Level | $1.50 | $1.93 |
| Resistance Level | $2.44 | $2.05 |
| Average True Range (ATR) | 0.18 | 0.16 |
| MACD | 0.02 | 0.06 |
| Stochastic Oscillator | 13.50 | 76.19 |
Price Performance
Historical ComparisonAbout HERE Here Group Limited American Depositary Shares
Here Group Ltd is dedicated to creating collectible pop toys that evoke joy and emotional resonance. The group design and compelling storytelling, which provide users with a collecting experience that blends artistic value with emotional warmth, continuously convey a joyful and immersive brand culture. Adhering to the brand philosophy of joy, integrity, wonder, and co-creation, the company is building a vibrant ecosystem connecting creativity and emotion, working hand-in-hand with overall toy enthusiasts to create, share, and transmit dreams.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.